STEMCELL Technologies Opens New Office and Laboratories in Cambridge, UK
CAMBRIDGE, England– STEMCELL Technologies UK has recently celebrated the grand opening of their Cambridge-based facility. Founded by Dr. Allen Eaves, STEMCELL provides specialized reagents and tools that support research on cancer and other diseases, as well as cell therapy and regenerative medicine globally. Cambridge is a leading global hub for stem cell research. This, combined with its proximity to STEMCELL’s customers in the UK and Europe, makes the location a natural choice for continued investment by the company. [Read more…]
Boston, January 25, 2017 – Cytonome/ST, LLC announces it has signed the first application specific agreement to license its proprietary GigaSortTM Technology for commercial scale cell therapy production. A premier pharmaceutical company has signed on for rights to use the technology for their explicit disease indication. They will manufacture a critical cell therapy to address one of the major diseases afflicting aging populations globally.
